2012 Global Rabies Diagnostics Market Outlook: Test Volumes, Sales Forecasts, and Supplier Shares by Country


April 20, 2012
197 Pages - SKU: VPG3867656
License type:
I. Introduction
II. Worldwide Market and Technology Overview
A. Background
B. Diagnostic Tests
C. Vaccines and Drugs
D. Emerging Diagnostic Technologies
1. DNA Probes
a. Technology Overview
b. Amplification Methods
0 Polymerase Chain Reaction
- Robotics
- Temperature Cyclers
- PCR Variations
0 Immuno-PCR
0 QC-PCR
0 DAP-PCR
0 Ligase Chain Reaction
0 Branched DNA
0 Q-Beta Replicase
0 Nucleic-Acid Sequence-Based
0 Strand Displacement Activation
0 Self-Sustained Sequence Replicase
2. Monoclonal Antibodies
3. Immunoassays
a. Technological Principle
b. Enzyme Immunoassays (EIA)
0 Overview
0 ELISA
0 Dot Immunobinding Assays
0 Capillary Immunoassays
0 Particle-Membrane Capture Immunoassays
0 Enzyme Amplificationc. Fluorescent Immunoassays
0 Fluorescence Polarization
0 Time-Resolved Pulse Fluorescence
d. Luminescence
0 Chemiluminescence
0 Bioluminescence
e. Latex Agglutination
f. Immunoprecipitation
4. Differential Light Scattering
5. Microcomputers and Automation
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. MRI
11. Gel Microdroplets
12. Other
III. France: Test Volume and Diagnostics Sales Forecast by Market Segment
IV. Germany: Test Volume and Diagnostics Sales Forecast by Market Segment
V. Italy: Test Volume and Diagnostics Sales Forecast by Market Segment
VI. Japan: Test Volume and Diagnostics Sales Forecast by Market Segment
VII. Spain: Test Volume and Diagnostics Sales Forecast by Market Segment
VIII. UK: Test Volume and Diagnostics Sales Forecast by Market Segment
IX. USA: Market Size, Growth and Major Suppliers’ Sales and Market Shares
X. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative ArrangementsC. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
XI. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XII. Competitive Assessments
- Abbott
- Affymetrix
- Applera
- Beckman Coulter
- Becton Dickinson
- Binding Site
- Biomerica
- Biokit
- bioMerieux
- Bio-Rad
- Biotrol
- Biosite
- Biotest
- Caliper Technologies
- Cepheid
- Chemicon
- Daiichi
- DiaSorin- Diagast
- Diamedix
- Digene
- Eiken
- Enzo Biochem
- Fujirebio
- GenBio
- Gene-Tec
- Hemagen
- Immunetics
- Innogenetics
- Inverness
- J&J
- Meridian
- Nanogen
- Nissui
- Olympus
- Provalis
- Roche
- Saliva Diagnostic
- SeraCare
- Siemens
- Third Wave Technologies
- Thermo Fisher
- Tosho
- Trinity Biotech
- Tropix
- Wampole Labs
- Zenith
- Zeus


List of Tables
France Rabies Test Volume and Diagnostics Sales Forecast by Market Segment
Germany Rabies Test Volume and Diagnostics Sales Forecast by Market Segment
Italy Rabies Test Volume and Diagnostics Sales Forecast by Market Segment
Japan Rabies Test Volume and Diagnostics Sales Forecast by Market Segment
Spain Rabies Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Rabies Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Rabies Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Rabies Testing Market Diagnostics Sales by Major Supplier